VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
LWAY
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
LWAYLifeway Foods, Inc.
$29.92$457M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksLWAYFinancials

Lifeway Foods, Inc. (LWAY) Financials

30Y historyFree accessUpdated daily

Revenue growth accelerated to 36.7% in 2026Q1, yet operating margins remain constrained at 10.0% due to persistent SG&A scaling and volatile gross margins that have fluctuated between 23.9% and 30.3% over the last ten quarters.

LWAY Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09Dec'08Dec'07Dec'06Dec'05Dec'04Dec'03Dec'02Dec'01Dec'00Dec'99Dec'98Dec'97Dec'96
Sales/Revenue229.42M212.5M186.82M160.12M141.57M119.06M102.03M93.66M103.35M118.89M123.88M118.59M118.96M97.52M81.35M69.97M58.5M58.12M44.46M38.73M27.72M20.13M16.32M14.88M12.21M10.68M9.18M7.9M6.8M6M5.3M
Revenue Growth %21.85%13.74%16.67%13.11%18.9%16.7%8.93%-9.37%-13.07%-4.02%4.46%-0.31%21.98%19.88%16.27%19.61%0.66%30.71%14.8%39.71%37.7%23.36%9.69%21.83%14.3%16.42%16.16%16.18%13.33%13.21%17.78%
Cost of Goods Sold163.98M154.29M138.25M117.68M114.78M90.36M75.09M71.51M77.49M88.2M88.85M86.99M90.1M69.92M53.93M47.42M38.32M37.22M31.7M26.31M17.08M11.66M9.03M7.84M6.74M6.45M4.7M4.3M3.3M3.1M2.7M
COGS % of Revenue-72.61%74%73.49%81.08%75.89%73.6%76.35%74.98%74.18%71.72%73.35%75.74%71.69%66.29%67.77%65.51%64.04%71.31%67.93%61.62%57.94%55.36%52.7%55.22%60.36%51.2%54.43%48.53%51.67%50.94%
Gross Profit65.44M58.21M48.57M42.44M26.79M28.71M26.93M22.15M25.86M30.7M35.03M31.6M28.86M27.61M27.43M22.55M20.18M20.9M12.76M12.42M10.64M8.47M7.28M7.04M5.47M4.23M4.48M3.6M3.5M2.9M2.6M
Gross Margin %28.52%27.39%26%26.51%18.92%24.11%26.4%23.65%25.02%25.82%28.28%26.65%24.26%28.31%33.71%32.23%34.49%35.96%28.69%32.07%38.38%42.06%44.64%47.3%44.78%39.64%48.8%45.57%51.47%48.33%49.06%
Gross Profit Growth %-19.83%14.45%58.44%-6.7%6.6%21.6%-14.34%-15.76%-12.38%10.86%9.49%4.55%0.66%21.62%11.75%-3.44%63.81%2.72%16.74%25.64%16.25%3.51%28.69%29.12%-5.44%24.4%2.86%20.69%11.54%4%
Operating Expenses44.51M42.03M34.72M25.45M24.44M22.83M22.01M24.08M27.72M31.22M28.95M27.2M24.44M19.59M18.58M17.47M13.9M11.96M8.57M21.87M6.41M5.07M4.33M3.56M2.89M2.8M3.32M2.6M2.2M1.8M1.6M
OpEx % of Revenue-19.78%18.59%15.89%17.26%19.17%21.57%25.71%26.83%26.26%23.37%22.94%20.54%20.09%22.84%24.97%23.77%20.58%19.27%56.48%23.12%25.17%26.56%23.92%23.67%26.19%36.14%32.91%32.35%30%30.19%
Selling, General & Admin43.06M41.49M34.18M24.91M23.9M22.71M21.86M23.89M27.09M30.55M28.25M26.48M23.72M18.88M17.83M16.69M13.18M11.28M8.25M7.66M6.41M5.07M4.33M3.56M2.89M2.8M2.71M2.2M1.8M1.5M1.4M
SG&A % of Revenue-19.53%18.3%15.55%16.88%19.07%21.42%25.51%26.21%25.7%22.8%22.33%19.94%19.36%21.91%23.85%22.53%19.41%18.55%19.78%23.12%25.17%26.56%23.92%23.67%26.19%29.5%27.85%26.47%25%26.42%
Research & Development0000000000000000000000000000000
R&D % of Revenue-------------------------------
Other Operating Expenses1.4M540K540K540K540K122K152K192K16K2K71K7K12.49K22.3K1.12K7.15K11.79K676.79K319.45K14.21M000000609.52K400K400K300K200K
Operating Income20.92M16.17M13.85M17M2.35M5.88M4.92M-1.93M-3.11M-526K6.08M4.4M4.42M8.02M8.84M5.08M6.27M8.94M4.19M-9.45M4.23M3.4M2.95M3.48M2.58M1.44M1.16M1M1.3M1.1M1M
Operating Margin %9.12%7.61%7.41%10.61%1.66%4.94%4.83%-2.06%-3.01%-0.44%4.91%3.71%3.72%8.22%10.87%7.26%10.73%15.38%9.43%-24.41%15.26%16.9%18.08%23.38%21.11%13.45%12.66%12.66%19.12%18.33%18.87%
Operating Income Growth %-16.75%-18.49%623.5%-60.05%19.44%354.68%37.85%-491.25%-108.64%38.2%-0.44%-44.83%-9.37%74.23%-19.1%-29.8%113.28%144.33%-323.47%24.37%15.28%-15.18%34.95%79.35%23.68%16.21%-23.08%18.18%10%42.86%
EBITDA23.97M20.15M17.24M20.16M5.32M8.75M8.16M1.41M367K2.59M9.11M7.53M7.67M8.73M11.23M7.41M8.39M10.75M5.28M-8.4M4.99M4.05M3.62M4.17M3.39M2.21M1.77M1.4M1.7M1.4M1.2M
EBITDA Margin %10.45%9.48%9.23%12.59%3.76%7.35%8%1.5%0.36%2.18%7.35%6.35%6.45%8.95%13.8%10.59%14.35%18.5%11.88%-21.7%18%20.13%22.19%28.01%27.72%20.73%19.31%17.72%25%23.33%22.64%
EBITDA Growth %55.73%16.9%-14.48%278.82%-39.21%7.24%480.93%282.83%-85.81%-71.6%20.88%-1.85%-12.08%-22.27%51.47%-11.67%-21.93%103.44%162.88%-268.44%23.11%11.93%-13.12%23.09%52.86%25%26.54%-17.65%21.43%16.67%33.33%
D&A (Non-Cash Add-back)3.04M3.98M3.39M3.16M2.97M2.87M3.24M3.34M3.48M3.11M3.02M3.13M3.25M712.8K2.38M2.34M2.12M1.81M1.09M1.05M758.75K650.95K669.99K688.31K807.68K777.35K609.52K400K400K300K200K
EBIT21.11M16.17M14.07M17.03M2.11M5.73M4.95M1.48M-3.04M-562K5.86M4.23M4.48M8.06M9M5.08M6.8M8.89M2.89M-9.45M4.23M3.4M2.95M3.48M2.58M1.44M1.16M1.01M1.3M1.1M1M
Net Interest Income5K-77K-105K-384K-267K-116K-118K-249K-271K-242K-220K-124K-155K-87K-92.24K-176.73K-90.44K-243.66K44.71K350.29K388.34K323.37K185.57K96.85K187.36K0368.99K0000
Interest Income00000000000112K122K116.38K85.38K70.61K260.55K199.05K343.33K350.29K388.34K323.37K185.57K96.85K187.36K0368.99K0000
Interest Expense-5K77K105K384K267K116K118K249K271K242K220K236K277K203.37K177.62K247.34K351K442.7K298.62K000000000000
Other Income/Expense54K3.51M117K-346K-508K-264K-95K3.17M-201K-278K-448K-411K-37K-158.97K-19.84K-243.23K171.82K-489.72K-1.6M14.42M410.77K681.7K491.77K97.84K-105.62K374.27K291.29K100K0100K0
Pretax Income20.98M19.69M13.97M16.65M1.84M5.62M4.83M1.24M-3.31M-804K5.64M3.99M4.4M7.84M8.82M4.83M6.45M8.45M2.59M4.97M4.64M4.08M3.44M3.58M2.47M1.81M1.45M1.1M1.3M1.2M1M
Pretax Margin %9.14%9.26%7.48%10.4%1.3%4.72%4.73%1.32%-3.2%-0.68%4.55%3.37%3.7%8.04%10.85%6.91%11.02%14.54%5.83%12.82%16.74%20.28%21.09%24.04%20.24%16.96%15.84%13.92%19.12%20%18.87%
Income Tax5.98M5.83M4.94M5.28M917K2.31M1.6M782K-225K-458K2.16M2.02M1.56M2.87M3.21M1.98M2.82M2.88M679.79K1.81M1.75M1.53M1.39M1.35M943.34K590.59K526.29K400K500K500K400K
Effective Tax Rate %28.53%29.6%35.39%31.73%49.81%41.04%33.06%63.32%6.8%56.97%38.28%50.6%35.4%36.56%36.32%40.92%43.81%34.08%26.23%36.5%37.6%37.58%40.39%37.87%38.16%32.6%36.21%36.36%38.46%41.67%40%
Net Income14.99M13.86M9.03M11.37M924K3.31M3.23M453K-3.09M-346K3.48M1.97M2.84M4.97M5.62M2.86M3.62M5.57M1.91M3.15M2.9M2.55M2.05M2.22M1.53M1.22M927.1K700K800K700K600K
Net Margin %6.54%6.52%4.83%7.1%0.65%2.78%3.17%0.48%-2.99%-0.29%2.81%1.66%2.39%5.1%6.91%4.08%6.19%9.58%4.3%8.14%10.45%12.66%12.57%14.93%12.52%11.43%10.1%8.86%11.76%11.67%11.32%
Net Income Growth %47.87%53.56%-20.6%1130.19%-72.09%2.44%613.47%114.68%-791.91%-109.95%76.42%-30.57%-42.91%-11.47%96.81%-21.17%-34.96%191.26%-39.34%8.87%13.63%24.19%-7.65%45.35%25.21%31.69%32.44%-12.5%14.29%16.67%50%
Net Income (Continuing)14.99M13.86M9.03M11.37M924K3.31M3.23M453K-3.09M-346K3.48M1.97M1.96M4.99M5.62M2.86M3.62M5.57M1.91M3.15M2.9M2.55M2.05M2.22M1.53M1.22M927.1K700K800K700K600K
Discontinued Operations0000000000000000000000000000000
Minority Interest0000000000000000000000000000000
EPS (Diluted)0.960.890.590.750.060.210.210.03-0.19-0.020.220.120.170.300.340.170.220.330.110.190.170.150.120.130.090.070.050.040.050.050.04
EPS Growth %42.82%50.85%-21.33%1175.51%-72%0%631.71%115.11%-783.72%-109.77%83.33%-29.41%-43.33%-11.76%100%-22.73%-33.33%200%-42.11%11.76%13.33%25%-7.69%44.44%28.57%33.33%23.53%-15%5.26%18.75%33.33%
EPS (Basic)-0.910.610.780.060.210.210.03-0.19-0.020.220.120.170.300.340.170.220.330.110.190.170.150.120.130.090.070.050.040.050.050.04
Diluted Shares Outstanding15.58M15.54M15.27M15.1M15.72M15.77M15.77M15.8M16.32M16.11M16.16M16.33M16.35M16.35M16.37M16.44M16.66M16.8M16.77M16.86M16.83M16.81M16.88M16.87M17.06M17.27M17.27M16.47M15.13M14.74M15.11M
Basic Shares Outstanding15.23M15.2M14.77M14.67M15.4M15.54M15.6M15.75M15.87M16.11M16.16M16.33M16.35M16.35M16.37M16.44M16.66M16.8M16.77M16.86M16.83M16.81M16.88M16.87M17.06M17.27M17.27M16.47M15.13M14.74M15.11M
Dividend Payout Ratio-------------26.29%20.4%----------------

Key Metrics

Growth RegimeAccelerating
ProfitabilityModerate
Balance SheetFortress
Cash FlowRobust
Top Statement Risk

Commodity cost volatility exposure

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q1)

Revenue Growth Momentum Accelerates Sharply

As indicated by the most recent quarterly financial data, LWAY achieved a significant revenue expansion of 36.7% year-over-year in 2026Q1, marking a notable departure from the more modest growth rates observed throughout the 2024 fiscal year and suggesting a potential inflection in consumer demand for probiotic products.

The acceleration to $63.0 million in quarterly revenue suggests that the company's core kefir offerings are successfully capturing broader market share or benefiting from increased household penetration. Investors should monitor whether this growth is sustainable or if it reflects temporary promotional activity that may pressure future margins.

Gross Margin Sensitivity to Inputs

Based on reported income statements, Lifeway's gross margin has fluctuated between 23.9% and 30.3% over the last ten quarters, reflecting the company's inherent exposure to volatile Class II dairy commodity prices and the ongoing challenge of maintaining pricing power in a competitive packaged foods environment.

While the 27.5% margin reported in 2026Q1 shows recovery from earlier lows, the lack of consistent expansion suggests that raw material costs remain a primary constraint on profitability. The company appears to be navigating these cycles by balancing price increases with volume, though structural margin expansion remains elusive.

Operating Leverage Remains Under Pressure

According to the provided financial statements, SG&A expenses have scaled alongside revenue growth, with 2026Q1 operating income of $6.3 million representing a 10.0% margin, which indicates that the company has yet to achieve significant operating leverage despite the recent surge in top-line performance.

The tendency for SG&A to rise in tandem with revenue suggests that the company is reinvesting heavily in marketing or distribution to defend its category leadership. This strategy may be necessary to fend off private label competition, but it limits the potential for rapid bottom-line expansion.

Earnings Quality Impacted by Volatility

As reported in recent filings, net income has exhibited significant volatility, ranging from a net loss in 2024Q4 to a $4.7 million profit in 2026Q1, a trend that appears influenced by non-operating items and periodic fluctuations in stock-based compensation and legal-related expenses.

The inconsistency in net income suggests that investors should focus on core operating performance rather than headline EPS, which may be distorted by one-time charges. The presence of stock-based compensation and potential litigation-related costs warrants further investigation into the true recurring earnings power of the business.

Sustainability of Recent Growth Trends

While the 36.7% revenue growth in 2026Q1 is impressive, a critical analysis of the income statement suggests that the company's reliance on a single product category may create a ceiling for long-term growth if market saturation or private label encroachment accelerates in the coming quarters.

Short-term growth spikes may be masking underlying competitive pressures that could lead to margin compression if the company is forced to increase trade promotions to maintain shelf space. Investors should be cautious about extrapolating recent growth rates without evidence of successful diversification beyond the core kefir line.

LWAY — Frequently Asked Questions

Quick answers to the most common questions about buying LWAY stock.

What was Lifeway Foods, Inc.'s (LWAY) revenue in 2025?

For fiscal year 2025, Lifeway Foods, Inc. (LWAY) reported total revenue of $212.5M. This represents a 3909.4% increase compared to $5.3M in 1996.

Is Lifeway Foods, Inc. (LWAY) profitable?

Lifeway Foods, Inc. (LWAY) is profitable, generating $13.9M in net income for the fiscal year ending 2025 with a net profit margin of 6.5%.

What is Lifeway Foods, Inc.'s operating profit margin?

Lifeway Foods, Inc. (LWAY) reported an operating income of $16.2M, resulting in an operating profit margin of 7.6%. This margin reflects the operational efficiency of the business before interest and taxes.

What is Lifeway Foods, Inc.'s gross profit and gross margin?

Lifeway Foods, Inc. (LWAY) generated $58.2M in gross profit for the year, representing a gross profit margin of 27.4%. This demonstrates the company's core pricing power and production efficiency.